Additivity and potentiation of IGF-I and GDNF in the complete rescue of postnatal motor neurons

M. M. Bilak, Andrea Markl Corse, R. W. Kuncl

Research output: Contribution to journalArticle

Abstract

Background: Both growth and survival of motor neurons may depend on multiple neurotrophic factors. Individually, insulin-like growth factor I (IGF-I) and glial cell line-derived neurotrophic factor (GDNF) are potent neurotrophic/survival factors for postnatal motor neurons. Methods: We used an organotypic spinal cord model of glutamatergic degeneration in ALS to investigate whether IGF-I and GDNF interact to enhance motor neuron survival, their trophic effect on choline acetyltransferase (ChAT) activity, and their effect on neurite outgrowth. Results: We show that the combination of IGF-I and GDNF at active doses (1) is additively neuroprotective, (2) completely rescues rat motor neurons from chronic glutamate-mediated toxicity, and (3) additively upregulates motor neuron ChAT activity. Further, IGF-I, which by itself does not promote neurite outgrowth in this model, potentiates the neurite promoting action of GDNF. Conclusion: The results predict that IGF-I combined with GDNF may provide a better therapy for the treatment of motor neuron disorders such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy.

Original languageEnglish (US)
Pages (from-to)83-91
Number of pages9
JournalAmyotrophic Lateral Sclerosis and Other Motor Neuron Disorders
Volume2
Issue number2
DOIs
StatePublished - 2001

Fingerprint

Glial Cell Line-Derived Neurotrophic Factor
Motor Neurons
Insulin-Like Growth Factor I
Choline O-Acetyltransferase
Nerve Growth Factors
Amyotrophic Lateral Sclerosis
Spinal Muscular Atrophy
Neurites
Glutamic Acid
Spinal Cord
Up-Regulation
Growth

Keywords

  • ALS
  • Glutamate
  • Neurotrophic factors
  • Spinal cord
  • Synergy

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

@article{f489ea9bb0e841d1bdd2512ff81e390a,
title = "Additivity and potentiation of IGF-I and GDNF in the complete rescue of postnatal motor neurons",
abstract = "Background: Both growth and survival of motor neurons may depend on multiple neurotrophic factors. Individually, insulin-like growth factor I (IGF-I) and glial cell line-derived neurotrophic factor (GDNF) are potent neurotrophic/survival factors for postnatal motor neurons. Methods: We used an organotypic spinal cord model of glutamatergic degeneration in ALS to investigate whether IGF-I and GDNF interact to enhance motor neuron survival, their trophic effect on choline acetyltransferase (ChAT) activity, and their effect on neurite outgrowth. Results: We show that the combination of IGF-I and GDNF at active doses (1) is additively neuroprotective, (2) completely rescues rat motor neurons from chronic glutamate-mediated toxicity, and (3) additively upregulates motor neuron ChAT activity. Further, IGF-I, which by itself does not promote neurite outgrowth in this model, potentiates the neurite promoting action of GDNF. Conclusion: The results predict that IGF-I combined with GDNF may provide a better therapy for the treatment of motor neuron disorders such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy.",
keywords = "ALS, Glutamate, Neurotrophic factors, Spinal cord, Synergy",
author = "Bilak, {M. M.} and Corse, {Andrea Markl} and Kuncl, {R. W.}",
year = "2001",
doi = "10.1080/146608201316949523",
language = "English (US)",
volume = "2",
pages = "83--91",
journal = "Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration",
issn = "2167-8421",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Additivity and potentiation of IGF-I and GDNF in the complete rescue of postnatal motor neurons

AU - Bilak, M. M.

AU - Corse, Andrea Markl

AU - Kuncl, R. W.

PY - 2001

Y1 - 2001

N2 - Background: Both growth and survival of motor neurons may depend on multiple neurotrophic factors. Individually, insulin-like growth factor I (IGF-I) and glial cell line-derived neurotrophic factor (GDNF) are potent neurotrophic/survival factors for postnatal motor neurons. Methods: We used an organotypic spinal cord model of glutamatergic degeneration in ALS to investigate whether IGF-I and GDNF interact to enhance motor neuron survival, their trophic effect on choline acetyltransferase (ChAT) activity, and their effect on neurite outgrowth. Results: We show that the combination of IGF-I and GDNF at active doses (1) is additively neuroprotective, (2) completely rescues rat motor neurons from chronic glutamate-mediated toxicity, and (3) additively upregulates motor neuron ChAT activity. Further, IGF-I, which by itself does not promote neurite outgrowth in this model, potentiates the neurite promoting action of GDNF. Conclusion: The results predict that IGF-I combined with GDNF may provide a better therapy for the treatment of motor neuron disorders such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy.

AB - Background: Both growth and survival of motor neurons may depend on multiple neurotrophic factors. Individually, insulin-like growth factor I (IGF-I) and glial cell line-derived neurotrophic factor (GDNF) are potent neurotrophic/survival factors for postnatal motor neurons. Methods: We used an organotypic spinal cord model of glutamatergic degeneration in ALS to investigate whether IGF-I and GDNF interact to enhance motor neuron survival, their trophic effect on choline acetyltransferase (ChAT) activity, and their effect on neurite outgrowth. Results: We show that the combination of IGF-I and GDNF at active doses (1) is additively neuroprotective, (2) completely rescues rat motor neurons from chronic glutamate-mediated toxicity, and (3) additively upregulates motor neuron ChAT activity. Further, IGF-I, which by itself does not promote neurite outgrowth in this model, potentiates the neurite promoting action of GDNF. Conclusion: The results predict that IGF-I combined with GDNF may provide a better therapy for the treatment of motor neuron disorders such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy.

KW - ALS

KW - Glutamate

KW - Neurotrophic factors

KW - Spinal cord

KW - Synergy

UR - http://www.scopus.com/inward/record.url?scp=0034806119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034806119&partnerID=8YFLogxK

U2 - 10.1080/146608201316949523

DO - 10.1080/146608201316949523

M3 - Article

C2 - 11675876

AN - SCOPUS:0034806119

VL - 2

SP - 83

EP - 91

JO - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

JF - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

SN - 2167-8421

IS - 2

ER -